Dr. Probst is the director of chemistry a Nitrome Biosciences, bringing 20 years of pharmaceutical industry experience. Previously he worked at Cor Therapeutics, Elan Pharmaceuticals, Igenica Biotherapeutics, and as a consultant. Dr. Probst was a team member that discovered Betrixaban and designed and synthesized ELND006 and ELND007, experimental treatments for Alzheimer’s disease. He is an author on 27 peer-reviewed journal articles, an inventor on 10 issued US patents and more than a dozen additional patent applications, and a contributor to 11 presentations or posters from scientific meetings. Dr. Probst holds a BS and Ph.D. in chemistry from UCLA and Stanford University, respectively.